It’s always jarring when I go to a scientific meeting, in this case the American Society of Clinical Oncology (ASCO) meeting, imbibe the latest clinical science on cancer, and then check back to see what the quacks are doing. On the other hand, there was a session at this year’s ASCO on “integrative oncology” (stay […]
